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Opioid use disorder (OUD) refers to the physical and psychological reliance on opioids. 
OUD costs the US healthcare systems $504 billion annually and poses significant 
mortality risk for patients. Understanding and mitigating the barriers to OUD treatment 
is a high-priority area. Current OUD treatment studies rely on surveys with low response 
rate because of social stigma. In this paper, we explore social media as a new data source 
to study OUD treatments. We develop the SImilarity Network-based DEep Learning 
(SINDEL) to discover barriers to OUD treatment from the patient narratives and address 
the challenge of morphs. SINDEL reaches an F1 score of 76.79%. Thirteen types of OUD 
treatment barriers were identified and verified by domain experts. This study contributes 
to IS literature by proposing a novel deep-learning-based analytical approach with 
impactful implications for health practitioners. 
Keywords:  Deep learning, text mining, opioid addiction, data science 
 
Introduction 
The misuse of and addiction to opioids, involving nonmedical use, misuse, or abuse of opioid medications 
(e.g., pain relievers), and use of illicit opioids (e.g., heroin), are epidemic and have become a serious public 
health crisis in the United States (NIH 2018a). It was estimated that in 2016, 11.8 million Americans 
misused prescription opioids or used illicit opioids (SAMHSA 2017). Among them, 2.1 million suffered from 
opioid addiction. This growing crisis devastates millions of Americans with opioid use disorder (OUD). 
OUD causes serious medical and financial consequences for patients and healthcare systems. In 2017, the 
number of overdose deaths involving opioids was six times higher than that in 1999 (CDC 2018). On 
average, 130 Americans die every day from opioid overdose (NIH 2018b). The ramifications of OUD go well 
beyond the healthcare realm. The Council of Economic Advisors at the White House estimated that in 2015, 
the cost of OUD was $504 billion, or 2.8 percent of the GDP that year (White House 2017).  
In response to the growing burden of OUD, society needs to work together to improve the access to 
treatment. Although many medical studies show that OUD treatments are effective and could prevent 
further ramifications, only 17.5% of patients with OUD receive treatment (NIDA 2018). In 2018, the US 
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Surgeon General stressed the urgency of understanding and removing the barriers to OUD treatment 
(Office of the Surgeon General 2018). Understanding these barriers forms the premise to decrease overdose 
mortality, reduce the transmission of infectious diseases, and lower healthcare expenditure (Robeznieks 
2018). In this study, we define the barriers to OUD treatment as patient self-described factors leading to 
the absence of OUD treatment. Our research objective is to propose and evaluate an innovative 
computational approach to understand the barriers to OUD treatment.  
Existing studies employed surveys to understand the barriers to OUD treatment (Hassamal et al. 2017; 
McKenna 2017; Stumbo et al. 2017). These survey studies are challenged by the narrow patient population, 
as individuals struggling with OUD often are difficult to reach if they are not actively under treatment. Social 
media can bridge this gap. In drug forums, in particular, patients share their experiences of taking 
prescription and illicit opioids. Due to the anonymous nature of these forums, patients are willing to 
elaborate on their real decision-making on OUD treatments (e.g., Figure 1). This large-scale patient self-
reported information creates an unprecedented potential to study the barriers to OUD treatment from the 
patient decision-making standpoint and facilitate analyses on heterogeneous patient groups in real time. 
To our best knowledge, no social media approach has been taken in OUD treatment research. 
 
 
Figure 1.  Examples of Patient Narratives about OUD Treatment 
 
Significant challenges still exist to understand patient perspectives in drug forums despite their enormous 
potential. First, the barriers to OUD treatment are sensitive to real-time events, causing them to vary over 
time. To facilitate effective and real-time surveillance for OUD treatment barriers, proactive and fine-
grained automated models are required. Second, patients prefer to use a wide variety of morphs (fake 
alternative names) to describe drugs and treatment options in order to avoid censorship and surveillance, 
entertain readers, or use personal writing styles.  
The literal meanings of the morphs are distant from their contextual meanings. The drift between the literal 
and contextual meanings of morphs poses a significant challenge for researchers, practitioners, and patients 
to understand the discussion. Motivated by the critical need for fine-grained and automated techniques to 
understand OUD treatment barriers in drug forums, we propose a novel computational method – SImilarity 
Network-based DEep Learning (SINDEL).  
SINDEL extends the state-of-the-art text mining model with a similarity network-based component and 
deep learning architecture. The similarity network-based component bridges the literal and contextual 
semantics of morphs and detects OUD treatment barriers accurately. The deep learning architecture 
enhances the learning performance on sparse OUD-related narratives through a recurrent and parallel 
hierarchical structure. 
Our study makes the following contributions to information systems literature, data analytical 
methodology, and healthcare practice. First, we develop a deep learning framework (SINDEL) to extract 
OUD treatment barriers from drug forums. SINDEL can be generalized to extract information from many 
other text genres containing specialized morphs, such as hacker forums, health social media, and product 
reviews.  
Second, our study falls into the category of computational design science research that aims to design 
analytical solutions to problems with social impact (Rai 2017). We develop an information system to 
address the opioid addiction problem and provide an automated framework to understand patient decision-
making.  
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Third, our empirical findings complement current behavioral health science research on OUD treatments 
with comprehensive patient experience data. We discover 13 types of OUD treatment barriers. Many of the 
OUD treatment barriers that we discover have not been noted by prior survey studies, such as side effects 
of treatment, concerns about buprenorphine or methadone addiction, poor patient-physician relationship, 
and depressed mental status. We provide valuable implications for medical professionals and policymakers 
to understand individual opioid-taking behavior and the real treatment barriers faced by patients. Tailored 
intervention measures can be taken accordingly to prevent medical and financial ramifications, improve 
OUD management, and reverse the opioid crisis. 
Literature Review 
OUD Treatments Barriers and Social Media Analytics 
Surveys or interviews are commonly used to investigate the barriers to OUD treatment. The barriers to OUD 
treatment identified in these studies can be categorized into three categories: 1) System-related: the factors 
related to healthcare systems and regulations, such as government and insurance policies (Oliva et al. 2011) 
and funding barriers (Knudsen et al. 2011); 2) Provider-related: the factors related to health providers, such 
as lack of DEA waiver (Andrilla et al. 2017), lack of institutional support (Hutchinson et al. 2014), lack of 
resources (Wolfe et al. 2010), and geographic constraints (Sharma et al. 2017); 3) Patient-related: patient-
specific factors, such as the fear of pain (Stumbo et al. 2017) and lack of information on treatments 
(Hassamal et al. 2017). 
Current studies investigated the barriers to OUD treatment via surveys and interviews, which offer only 
cursory descriptions of some well-known and hypothesized barriers, lacking depth and comprehensiveness 
(Larochelle et al. 2016). The surveys only capture a snapshot of barriers. In reality, many patient-level 
barriers are complicated by patient characteristics and policy changes, causing them to vary over time. The 
time-invariant analyses in surveys are unlikely to offer a comprehensive understanding of treatment 
barriers. Furthermore, patients are reluctant to disclose their issues with OUD treatments, especially illicit 
drug users. 
Health big data from social media platforms makes innovative projects possible and opens opportunities 
for investigations that can yield insights into and understanding of issues such as patient decision-making, 
human motivation, and social phenomena (Baesens et al. 2014). Because of the anonymous nature of social 
media, many patients, including illicit drug users, actively share their drug-taking experience with their 
peers. This patient self-reported experience not only provides real-time and dynamic information but also 
covers an unprecedent scale of the patient population with heterogeneous characteristics. Yet, no social 
media approach has been taken in OUD treatment studies. 
Despite the enormous potential of social media, significant challenges still exist. When describing OUD 
treatments, patients use many morphs (fake alternative names) to represent drugs and treatment options. 
This is because users attempt to avoid censorship and surveillance or use them as idiomatic expressions. 
For instance, heroin can be described as H, hero, and China white by different users. Conventional text 
mining methods are not capable of interpreting the real semantics of the morphs. 
Morphology and Deep Learning 
Morphology is the study of words, how they are formed, and their relationship to other words in a language. 
Similar to the drug morphs and patient idiomatic expressions in drug forums, morphology studies tackle 
internet slang (Huang et al. 2017; Sha et al. 2017), synonyms (He et al. 2016; Qu et al. 2017), and 
semantically similar terms (Yao et al. 2018; Zhang et al. 2016). The main body of literature in morphology 
utilizes distributed representation and deep learning methods, such as word embedding and BLSTM, to 
interpret the semantics of morphs. 
Word embedding is a vector-based representation of words commonly used in deep learning models for 
natural language processing. Skip-gram and CBOW are the most common word embedding models (Levy 
and Goldberg 2014). They learn the neighboring words of a focal word within a window size across the 
corpus and predict its most likely neighbors. 
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The state-of-the-art deep learning models to process text data are recurrent neural networks (RNNs) and 
Long Short-Term Memory (LSTM). An RNN contains a self-connected recurrent unit. At each time step, an 
RNN takes both the last hidden state and the current input to compute the current hidden state. LSTMs are 
a variant of RNNs. An LSTM contains an input gate, a forget gate, an output gate, a memory cell, and a 
hidden state.  
Standard deep learning is still challenging for tackling morphology, which is exacerbated by online social 
media platforms and the nature of OUD discussions. The morphs of drugs and treatment options are often 
used in OUD discussions. Usually, the literal meaning of these morphs is distant from their contextual 
meaning. Morphs for drugs in the same class are semantically closer than those across drug classes. Each 
opioid class has a unique effect, regimen, and instruction, leading to varying semantic context in OUD 
discussions. Oxycodone is a semi-synthetic opioid, the morphs of which include oxy, O.C., oxycet, 
oxycontin, and more. The morphs of heroin include H, China white, and more. Oxy and O.C. are not simply 
morphs of opioid drugs, but they represent the same drug class (oxycodone) as well. Therefore, oxy and 
O.C. are more closely related than oxy and China white. Although standard deep learning could capture the 
semantic meaning of the words, the interconnected relationships within the same opioid class are neglected. 
 
The vector representation of words enables deep learning methods to demonstrate outstanding 
performance in various natural language understanding tasks. It models the semantic context of words 
using the neighboring words of the focal word. However, in addition to the semantic relatedness to local 
neighboring words, key entities of interest, such as drug names and treatment effects, are related due to the 
medical context. Therefore, we are motivated to propose a new deep learning architecture that incorporates 
the vector representation of words and semantic similarity in a network to extract OUD treatment barriers 
from drug forums. 
Research Method 
The OUD treatment barrier mining problem has two objectives: barrier extraction and barrier clustering. 
Barrier extraction identifies patient self-described OUD treatment barriers. Since patients use different 
expressions to describe the same type of barrier, barrier clustering groups the identified OUD treatment 
barriers based on their semantic meaning. The process of the OUD treatment barrier mining is shown in 
Figure 2. The novelty of our approach is highlighted in red. 
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Figure 2.  The OUD Treatment Barrier Mining Framework 
 
The proposed OUD treatment barrier mining approach receives a sentence from drug forums as the input. 
Two parallel representation models represent the sentence with two vectors. Branch 1 utilizes word 
embedding to generate semantic vectors for each word. Branch 2 creates a similarity network of words and 
generates a network representation for each word. The two representations are concatenated in the hidden 
layers which further recognize the OUD treatment barriers in the sentence. A clustering model is utilized to 
cluster the extracted barriers into meaningful categories of OUD treatment barriers. 
The Similarity Network-Based Representation 
The proposed similarity network-based representation contains two parallel representations. The first 
representation is a word embedding representation to capture the semantic meaning of words, so that 
morphs can be interpreted as their intended meaning. Let 𝑆 be a training sequence [𝑤$, 𝑤&,…,𝑤']. Variable 𝑤) denotes word 𝑖 in the sequence. The training objective is to maximize the objective function in Equation 
7.  
																																																																				𝐿 = 1𝑇0 0 log𝑝5𝑤6789𝑤6:;<=8=<,8>?'6@$ .																																																																				(7) 
Parameter 𝑇 denotes the number of training words. Parameter 𝑐 is the window size (the words that appear 
within a distance of 𝑐 words). Variables 𝑤678 are the words surrounding 𝑤6. 
The second representation aims to construct a network of words in order to capture the interconnected 
relationships. In this network 𝐺 = (𝑉, 𝐸), each node 𝑉 is a word, and the edge 𝐸 is the semantic similarity 
between words. As such, each word is linked to a set of words that are closely related. For instance, oxy will 
be linked with O.C. and Oxycet, because they are the most similar morphs. Oxy will not be linked with China 
white, because they represent different drug classes. This word similarity network is capable of addressing 
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the limitation of word embedding by considering the semantic relationships among entities of interests. 
Instead of using the representation of the focal word, we use similar words that are connected to the focal 
word as the second representation for the focal word. Figure 3 shows an example. 
 
 
Figure 3.  An Example of a Word Similarity Network 
 
In the simple example in Figure 3, Oxycodone (𝑤($)) is linked to oxy, O.C., Oxycet, and Oxycontin, because 
they belong to the same drug class. We use 𝑤(&), 𝑤(I), 𝑤(J), and 𝑤(K) to represent 𝑤($). Likewise, China 
white, H, and hero are linked to heroin. We use 𝑤(L), 𝑤(M), and 𝑤(N) to represent 𝑤(O). In our corpus, we 
construct a similarity network for all words and compute the similarity between each pair of words. We 
select a set of most similar words for each word and link them together. The number of similar words is 
determined in the empirical analyses with the highest performance. Word similarity is computed using the 
cosine similarity of word embedding as shown in Equation 8.  																																																																																	𝑠𝑖𝑚)8 = 𝒙()) ∙ 𝒙(8)∥ 𝒙()) ∥∥ 𝒙(8) ∥.																																																																															(8) 
Variables 𝒙()) and 𝒙(8) are the word embedding of word 𝑤()) and 𝑤(8). Given word 𝑤, let 𝑤($), 𝑤(&), … ,𝑤($?) 
be the top ten words that are the most similar to word 𝑤. Let 𝑠𝑖𝑚($), 𝑠𝑖𝑚(&), … , 𝑠𝑖𝑚($?) be the similarity 
between word 𝑤  and the other ten words. Let 𝒙($), 𝒙(&), … , 𝒙($?)  be the word embedding for 𝑤($), 𝑤(&), … ,𝑤($?). The similarity network representation of word 𝑤 is defined in Equation 9. 
																																																																																				𝒙W =0𝑠𝑖𝑚())𝒙())$?)@$ .																																																																																				(9) 
A Deep Learning Architecture 
To effectively extract the barriers to OUD treatment, we utilize a bidirectional long short-term memory 
(BLSTM) architecture. We devise a multi-view BLSTM model that processes the word embedding 
representation and the similarity network representation in parallel. The multi-view BSLTM model 
contains two branches. Each branch has independent BLSTM layers that contain LSTM units. Our model 
is called SImilarity Network-based DEep Learning (SINDEL). 
The LSTM units in branch one take the word embedding as the input, and the LSTM units in branch two 
take the similarity network representation as the input. The computational process for branch two is shown 
in Equations 10-15. The computational process in the first branch is the same, except that the input at each 
time step is word embedding 𝒙(6) instead of similarity network representation 𝒙W(6). 
Similarity network-based input gate: 𝒊W(6) = 𝜎5𝑾\)𝒙W(6) + 𝑼\)𝒉W(6;$) + 𝒃\):;																																											(10)	 
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Similarity network-based forget gate: 𝒇W(6) = 𝜎5𝑾\d𝒙W(6) + 𝑼\d𝒉W(6;$) + 𝒃\d:;																																						(11) 
Similarity network-based output gate: 𝒐W(6) = 𝜎5𝑾\f𝒙W(6) + 𝑼\f𝒉W(6;$) + 𝒃\f:;																																				(12) 
Similarity network-based cell state: 𝒖W(6) = 𝜎5𝑾\i𝒙W(6) + 𝑼\i𝒉W(6;$) + 𝒃\i:;																																									(13) 
Similarity network-based memory cell: 𝒄W(6) = 𝒊W(6) ∘ 𝒖W(6) + 𝒇W(6) ∘ 𝒄W(6;$); 																																																(14) 
Similarity network-based hidden state: 𝒉W(6) = 𝒐W(6) ∘ 𝑡𝑎𝑛h5𝒄W(6):.																																																														(15) 
Variable 𝒙W(6) is the current input, and 𝒉W(6;$) is the previous hidden state. Parameters 𝑾,	𝑼, and	𝒃 are weight 
parameters with values between 0 and 1. Each forward or backward hidden state has 128 dimensions. We 
condense useful information from the 300-dimensional 𝒙(6) to 128 dimensions in the LSTM cell, following 
prior studies (Chan and Lane 2015; Rao et al. 2015). The learning rate in gradient descent is 0.1. The dropout 
rate is 0.2. 
The above computation is processed independently for the word embedding branch and the similarity 
network branch. Each branch obtains a hidden state in the last time step. The final hidden states of branch 
one and two are further concatenated as an integrated model. Figure 4 shows a graphic illustration of the 
model architecture. The red part indicates the innovation of this study. 
 
Figure 4.  Similarity Network-Based Deep Learning Architecture 
 
The input to the SINDEL model is a sentence from the research corpus. The sentence is represented with 
word embedding and the similarity network representation. Two BLSTM layers process these two 
representations in parallel. Finally, a Softmax layer (Equation 16) is stacked on the top to predict the word 
type (OUD treatment barrier or not). 
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																																																																															𝑝(𝑦 = 𝑗|𝒙) = 𝑒𝒙T𝒘x∑ 𝑒𝒙T𝒘z{|@$ .																																																																										(16) 




The research testbed comes from a leading health IT platform Drugs-Forum.com, which contains a large 
collection of patient discussions about drug use and recovery. This platform provides the opportunity for 
opioid users to interact with peers without being judged. Because of the anonymity and the specificity of 
the platform, opioid users elaborate on their drug use, addiction, and treatment experience. This platform 
also allows illicit drug users to share their experience with illicit drugs, such as heroin, cocaine, and fentanyl. 
We collected the posts from Drugs-Forum related to drug use from the start of Drugs-Forum to September 
1, 2018. The raw dataset encompasses 27,154 posts. We randomly sampled 3,000 posts related to OUD 
treatment. Four expert annotators read the posts and annotated the OUD treatment barriers for model 
training purposes. The IOB labeling scheme is adapted to assign tags for each word in a sentence. Each 
word has a label suggesting if it is inside (I), outside (O), or the beginning (B) of an expression of OUD 
treatment barriers. Figure 5 shows an example of the annotation.  
 
 
Figure 5. Annotation Example 
 
To test inter-annotator reliability, we leverage Cohen’s Kappa. The Kappa value for the OUD treatment 
barrier annotation is 0.92, indicating excellent reliability. A fifth expert annotator reviewed disagreements 
and made the final judgment. We further segmented the posts into sentences with the sentence boundary 
detection package from NLTK. A total of 40,917 sentences were generated. We chose 70% of the annotated 
data as the training set, 10% as the validation set, and the remaining 20% as the test set. 
Evaluation of Extracting OUD Treatment Barriers 
As shown in Table 1, our SINDEL model outperforms the conventional machine learning methods (SVM, 
LR, NB, and CRF) by a very large margin in F1 score and precision. CRF achieves the highest precision 
(78.46%) among the common baseline methods. SINDEL outperforms CRF in precision by 6.85%. LR has 
the highest F1 score (50.01%) among the baseline methods. SINDEL still outperforms LR in F1 score by 
53.91%. NB achieves the highest recall, because it recognizes most instances as OUD treatment barriers 
(very low precision), which is not feasible for practical use. 
 
Table 1. Evaluation of SINDEL against the Conventional Machine 
Learning Methods 
Method Precision Recall F1 score 
SVM 58.10% 40.09% 47.40% 
LR 45.25% 61.15% 50.01% 
NB 22.54% 95.50% 36.47% 
CRF 78.46% 36.59% 49.90% 
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SINDEL (Ours) 85.31% 70.14% 76.97% 
Table 1. Evaluation of SINDEL against the Conventional Machine Learning Methods 
To test the statistical significance of the performance improvement of the SINDEL model, we repeat the 
training and testing procedures for each model 20 times and conduct t-tests to compare the performance 
of SINDEL against the conventional machine learning baseline models. The t-test results summarized in 
Table 2 indicate that our proposed SINDEL significantly outperforms all the baseline models (p < 0.001).  
 
Table 2. Pairwise T-tests for SINDEL against the Conventional Machine Learning Methods 
Method Pair Precision Recall F1 score 
SINDEL vs SVM < 0.001*** < 0.001*** < 0.001*** 
SINDEL vs LR < 0.001*** < 0.001*** < 0.001*** 
SINDEL vs NB < 0.001*** < 0.001*** < 0.001*** 
SINDEL vs CRF < 0.001*** < 0.001*** < 0.001*** 
*: p < 0.05; **: p < 0.01; ***: p < 0.001 
Table 2. Evaluation of SINDEL against the Conventional Machine Learning Methods 
We also compare our SINDEL model with state-of-the-art deep learning methods. The results in Table 3 
show that SINDEL outperforms RNN, LSTM, and BLSTM in all three evaluation metrics. BLSTM achieves 
the best results among the deep learning baseline methods due to the advantages of the bidirectional 
architecture. SINDEL improves upon BLSTM in precision by 4.15%, recall by 11.96%, and F1 score by 
8.44%. In Table 4, the pairwise t-tests for SINDEL against the deep learning methods indicate the 
performance improvement of our SINDEL is statistically significant. The superior performance of SINDEL 
against all the baseline methods in Table 1 and Table 3 demonstrates the effectiveness of the proposed 
similarity network-based deep learning in extracting OUD treatment barriers. 
 
Table 3. Evaluation of SINDEL against the Deep Learning Models 
Method Precision Recall F1 score 
RNN 75.19% 48.49% 58.80% 
LSTM 71.90% 54.48% 61.77% 
BLSTM 81.91% 62.65% 70.98% 
SINDEL (Ours) 85.31% 70.14% 76.97% 
Table 3. Evaluation of SINDEL against the Deep Learning Models 
Table 4. Pairwise T-tests for SINDEL against the Deep Learning Models 
Method Pair Precision Recall F1 score 
SINDEL vs RNN < 0.001*** < 0.001*** < 0.001*** 
SINDEL vs LSTM < 0.001*** < 0.001*** < 0.001*** 
SINDEL vs BLSTM < 0.001*** < 0.001*** < 0.001*** 
*: p < 0.05; **: p < 0.01; ***: p < 0.001 
Table 4. Pairwise T-tests for SINDEL against the Deep Learning Models 
The SINDEL model utilizes word embedding and the similarity network as the representation. We utilize 
the word2vec model to generate word embedding in the previous analyses. We further test the robustness 
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of our model by using other commonly adapted word embedding models including a locally-trained Skip-
gram model and GloVe. Table 5 shows the performance of these embedding models. Table 6 shows the 
significance of the performance comparison. 
 
Table 5. Evaluation of SINDEL Using Different Word Embeddings 
Method Precision Recall F1 score 
SINDEL with Skip-gram 80.09% 68.56% 73.87% 
SINDEL with GloVe 83.84% 59.14% 69.33% 
SINDEL (Ours) 85.31% 70.14% 76.97% 
Table 5. Evaluation of SINDEL Using Different Word Embeddings 
Table 6. Pairwise T-tests for SINDEL Using Different Word Embeddings 
Method Pair Precision Recall F1 score 
SINDEL (Ours) vs SINDEL with Skip-gram < 0.001*** < 0.01** < 0.001*** 
SINDEL (Ours) vs SINDEL with GloVe < 0.05* < 0.001*** < 0.001*** 
*: p < 0.05; **: p < 0.01; ***: p < 0.001  
Table 6. Pairwise T-tests for SINDEL Using Different Word Embeddings 
The word2vec model reaches the best performance among all word embedding models. The locally-trained 
Skip-gram achieves lower performance because the word embedding training size is smaller than that of 
word2vec. GloVe also has lower performance because many of the discussions in the entire dataset drift 
from OUD treatment. The global representation induces noisy information. 
The similarity network representation captures the interconnected relationships among similar morphs, 
thus identifying more morphs of OUD treatment barriers together with the original term. In Table 7, we 
show examples of the additional morphs that the similarity network could capture. 
 
Table 7. Examples of Morphs Captured by the Similarity Network Representation 
Original Term Similar Morphs Captured by the Similarity Network 
Heroin Dopesick, H, chinawhite 
Ache Achey, sore, bites 
Methadone Meth, M, MMT 
Table 7. Examples of Morphs Captured by the Similarity Network Representation 
In addition to heroin, the similarity network could capture dopesick, H, and chinawhite. Therefore, OUD 
treatment barriers mentioned together with dopesick, H, and chinawhite could be identified as well. Acne 
is a withdrawal reaction after treatment, which can be a barrier that prevents patients from receiving 
treatment. Other types of barrier symptoms (achy, sore, bites) are also extracted by the similarity network. 
Methadone is an OUD treatment medication. Patients may mention it when describing treatment barriers, 
such as methadone addiction and withdrawal. Morphs of methadone, such as meth, M, and MMT, are 
extracted together to improve the model performance. 
Clustering OUD Treatment Barriers 
The SINDEL model could extract the OUD treatment barriers from the research data. These barriers are 
the actual expressions that patients used in the drug forums. Many expressions may indicate the same type 
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of treatment barrier. We, therefore, cluster the extracted treatment barriers to identify the general types. 
We use k-means as the clustering method. 
To choose the optimal number of clusters, a medical expert panel, including two biomedical researchers, 
examined the clusters for medical relevance. Thirteen clusters are identified by the expert panel. Table 8 
shows the types of OUD treatment barriers. 
 
Table 8. Types of OUD Treatment Barriers 
Type Description Percentage1 Examples 
Lack of motivation The patient does not have 
motivation to quit opioids 
24.67% Don't have the time to go 
to a methadone clinic, 
CANT stop, doesn't want 
to quit 
Lack of medical literacy The patient lacks knowledge of 
consequences of addiction 
21.88% A waste of time, dying of 
boredom, don't have any 
desire to be clean 
Concerns about social 
stigma and job 
opportunities 
The patient is concerned about 
social stigma or afraid of losing 
jobs 
12.67% Fails a pre employment 
drug screen, new job 
training that requires no 
drug or medication use 
Afraid of withdraw 
reactions 
The patient is afraid of the 
withdrawals after quitting 
12.35% Hate withdrawals, 
precipitated withdrawals 
Side effects of treatment The patient is concerned about 
the side effects of treatment 
9.13% Headaches, migraines, 
insomnia 
Reliance because of 
chronic pain/fatigue 
The patient cannot stop opioids 
because of chronic pain 
5.64% I'm sick in pain, chronic 




The patient is concerned about 
buprenorphine or methadone 
addiction 
3.85% Methadone addiction 
High cost of treatment The patient cannot afford the 
treatment or insurance does 
not cover 
2.91% Expensive, unaffordable 
Poor patient-physician 
relationship 
The patient does not have good 
relationship with the providers 
2.19% Clinic denies me, doc 
was pissed 
Enjoy euphoric feeling of 
drugs 
The patient enjoys the euphoric 
feeling of opioids and does not 
want to quit 
1.70% Like dope, craving 
Depressed mental status The patient is depressed and 
does not want to receive 
treatment 
1.57% Severe depression 
Lack of accessibility Treatment is not accessible to 
patients 
0.63% No rehab 
Others Others 0.82% Can't, good 
 
1 The percentage of each barrier reflects the situation in drug forums, which may be different from the 
patient population. 
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Table 8. Types of OUD Treatment Barriers 
The results shed valuable insights to understand patient’s decisions about receiving OUD treatment. Lack 
of motivation is the most common barrier to receiving OUD treatments (24.67%). Although these patients 
are aware of the consequences of addiction, they postpone visits to health providers. To motivate these 
patients, social support and family encouragement are essential to help them receive treatment. Lack of 
medical literacy is also common among patients. These patients do not understand the ramifications of 
opioid addiction. Thus, they have no intention of being treated. Intervention strategies for this group of 
patients include patient education and informational support. 
In addition to the barriers that confirm prior literature, we also identified new barriers that have not been 
noted in prior survey studies, such as side effects of treatment, concerns about buprenorphine or 
methadone addiction, poor patient-physician relationships, and depressed mental status. These barriers 
have not been identified by survey studies because these barriers are sensitive and involve personal 
behavior. The patients are willing to share these undisclosed opinions in drug forums because of the 
anonymity.  
Uncovering these new barriers enables a deeper understanding of patients’ opioid addiction behavior and 
facilitates more effective intervention strategies. For instance, poor patient-physician relationship prevents 
patients from seeking addiction treatment. Overlooking this perspective devastates the efforts of other 
stakeholders. In order to improve opioid addiction management, health providers need to foster a healthy 
relationship with their patients. Depressed patients also have little motivation to seek treatments. This new 
finding provides guidance for caregivers to treat the depression disorder of the patients together with OUD.  
Conclusion 
Our research objective is to develop a computational approach for understanding the barriers to OUD 
treatment from the patients’ perspective. We designed a novel deep-learning-based approach to collect 
relevant patient discussions from drug forums, extract the OUD treatment barriers, and analyze the types 
of barriers. In line with the design science research methodology, we rigorously evaluated our model and 
compared it with state-of-the-art baseline models. Our SINDEL model outperforms all the baseline models, 
attributed to the similarity network-based component. The SINDEL model can be generalized in many 
other information retrieval tasks involving morphs. 
The SINDEL model extracted the OUD treatment barriers from drug forums. This is among the first attempt 
to analyze OUD treatment barriers from large-scale health social media data. The OUD treatment barriers 
detected in this study have profound implications for the key stakeholders, including physicians, patients, 
policymakers, pharmaceutical companies, and healthcare systems. These stakeholders could gain rich 
insights from the patient perspective and understand the real barriers faced by the patients. Being aware of 
these barriers allows proactive intervention and early preventions to avoid harmful outcomes caused by 
OUD. 
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